| Factor Information | |
|---|---|
| Data ID | 451 |
| Factor | Previous atrial fibrillation |
| Description | IART increases morbidity and mortality in CHD patients. Radiofrequency catheter ablation has evolved into the first-line treatment of this complication. |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | analyze the long-term outcomes after intra-atrial re-entrant tachycardia (IART) ablation in congenital heart disease (CHD). |
| p Value | <0.05 |
| OR | 3.08 |
| Conclusion | Ablation of IART in CHD is a challenging procedure, but after ablation in experienced centers, SR can be maintained in 78.3%. Predictors of recurrences are non-CTI–related IART, long PR interval, and previous or induced AF. A risk score based on these factors can be useful for recurrence prediction. |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 454 |
| CHD Type | isolated CHD |
| CHD Subtype | GVT/TOF/ASD/SV/VSD/AVSD/EA/other |
| Reference | |
|---|---|
| PMID | 29929671 |
| Year | 2018 |
| Title | Long-Term Follow-Up After Ablation of Intra-Atrial Re-Entrant Tachycardia in Patients With Congenital Heart Disease: Types and Predictors of Recurrence. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | prospective observational study | |
| Region | Barcelona,Spain | |
| Method | Clinical data, electrocardiograms (ECGs) in SR and during IART, and echocardiographic, ablation, and mapping data were recorded. | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | undergo a first ablation procedure for IART | |
| Group | atrial arrhythmia recurrence(Treatment) | no atrial arrhythmia recurrence(Control) |
| Number | 20 | 72 |
| Age | 36.7 ±15.4 years | 35.9±13.9 years |
| Gender (Male: Female) | 12:8 | 44:28 |
| Marker Level | 0.097 | 0.25 |
